Clinical trialNCT05386355CompletedInterventional

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool

SponsorIDeA States Pediatric Clinical Trials NetworkEnrollment1,934COVID-19 VaccinesPediatric ALLTelemedicineVaccine Hesitancy

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will determine the effectiveness of a vaccine communication mobile health app on parental decisions to vaccinate their children against coronavirus disease 2019 (COVID-19). The hypothesis is that unvaccinated children of caregivers assigned to the Vaccine Uptake app will be more likely to achieve COVID-19 vaccine series completion than those children whose caregivers are assigned to the General Health app.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Ellen Kerns, PhD
University of Nebraska
Principal Investigator
clinicaltrials.gov ↗
Paul Darden, MD
University of Arkansas
Principal Investigator
clinicaltrials.gov ↗
Russell J. McCulloh, MD
University of Nebraska
Principal Investigator
clinicaltrials.gov ↗
Songthip T Ounpraseuth, PhD
University of Arkansas
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Arkansas Children'S Research Institute
Little Rock, Arkansas, United States
Nemours Children'S Health
Wilmington, Delaware, United States
Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Norton Children'S Research Institute
Louisville, Kentucky, United States
Our Lady of the Lake Regional Medical Center
Baton Rouge, Louisiana, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Dartmouth Hitchcock Clinic
Lebanon, New Hampshire, United States
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Rhode Island Hospital
Providence, Rhode Island, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Avera Research Institute
Sioux Falls, South Dakota, United States
West Virginia University
Morgantown, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Jul 2022
Primary completion: 25 Sept 2023
Completion: 25 Sept 2023
Last update posted: 11 Mar 2025
Registered enrollment: 1,934
Registry id: NCT05386355

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.